Squarepoint’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$107K Buy
+42,346
New +$115K ﹤0.01% 4199
2026
Q1
– Sell
-11,866
Closed -$51.7K – 4525
2025
Q4
$51.7K Buy
+11,866
New +$64.1K ﹤0.01% 4126
2025
Q3
– Sell
-58,574
Closed -$168K – 4588
2025
Q2
$168K Buy
58,574
+10,152
+21% +$26.8K ﹤0.01% 4031
2025
Q1
$131K Buy
48,422
+31,563
+187% +$118K ﹤0.01% 4139
2024
Q4
$39.8K Sell
16,859
-9,798
-37% -$26.1K ﹤0.01% 4876
2024
Q3
$63.2K Sell
26,657
-11,607
-30% -$25.6K ﹤0.01% 3954
2024
Q2
$74.6K Buy
+38,264
New +$130K ﹤0.01% 3851

Other funds holding GNLX

Squarepoint's GNLX Position: Q3 2026 in Review

Squarepoint opened a new position in Genelux (GNLX) in Q3 2026: 42,346 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #4199 among its holdings. This is a return to the name: Squarepoint previously reported a position in GNLX as recently as Q4 2025.

Squarepoint first reported a position in GNLX in Q2 2024 and has held it in 7 quarters since. The position peaked at $168K in Q2 2025. 53 funds tracked by Wall St. Rank hold GNLX as of Q3 2026.

  • Squarepoint held 42,346 shares of Genelux worth $107K as of Q3 2026.
  • Genelux was a new Squarepoint position in Q3 2026.
  • Genelux made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4199 holding.
  • Squarepoint first reported a position in Genelux in Q2 2024 and has held it in 7 quarters since.
  • Squarepoint's Genelux position peaked at $168K in Q2 2025.
  • 53 funds tracked by Wall St. Rank held Genelux as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.